Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile andpharmaceutically acceptable salts thereof are provided as well as kits andarticles of manufacture comprising the pharmaceutical compositions as well asmethods of using the pharmaceutical compositions.